Purchase Order 75N91018P00524

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $20,930.00 on August 24, 2017, with final completion on December 23, 2017. The order is firm fixed price with no set-aside category. Work is performed at the awardee's facility in Bethesda, Maryland. The source does not specify the goods or services procured under this purchase order.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $10,775.16 on June 24, 2019, with completion by July 31, 2020. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price. The source does not specify the item or service being procured.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $7,250.88 on March 21, 2018, with an ultimate completion date of March 31, 2019. The order was issued without a set-aside and carries firm fixed-price terms. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $21,802.56, awarded September 15, 2017, with completion targeted for September 21, 2018. The order carries fixed-price pricing with economic price adjustment and involves no set-aside category. Place of performance is Bethesda, Maryland. The source does not specify the goods or services being procured.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $17,409.60 on December 21, 2018, with performance completion by December 31, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price; specific scope of work is not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $15,768.00 on August 11, 2017, with completion targeted for September 23, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The source does not specify the requirement details or originating solicitation.</p>

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $10,196.16 on December 9, 2020, with ultimate completion on December 10, 2020. Work is performed in Bethesda, Maryland. The order is a firm fixed-price service agreement with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $14,640.00 on February 4, 2020, with ultimate completion on February 4, 2021. The firm fixed-price order covers a service agreement with place of performance in Bethesda, Maryland. No small business set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $11,856.00 on May 30, 2018, with completion due May 31, 2019. The order was issued under firm fixed-price, commercial terms with no small business set-aside. Place of performance is Shelton, Connecticut. The source does not specify the items or services procured.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for a maintenance agreement valued at $10,158.72, with an award date of April 2, 2019 and ultimate completion date of May 14, 2020. Work is performed in Bethesda, Maryland. The order uses firm fixed-price pricing with no small business set-aside.</p>